Informations bibliographiques

Ligne directriceWHO updated recommendations on HIV clinical management: recommendations for a public health approach
Année de publication2025
Institution émettriceWorld Health Organization

Recommandation

Nouvelle

Use of oral two-drug antiretroviral regimens in HIV treatment. Dolutegravir + lamivudine (DTG+3TC) can be used for treatment simplification in adults and adolescents, with undetectable HIV viral load on 3-drug ARV regimens and without active hepatitis B infection.

Recommandé en faveur

Conditionnelle